Medical Costs of Ambulatory Patients with the AIDS-Related Complex (ARC) and/or Generalized Lymphadenopathy Syndrome (GLS) Related to HIV Infection, 1984-85
Related Articles
- AIDSSPEAK. // Body Politic;Dec86, Issue 133, p15
Presents the definition of several terms related to AIDS. ARC; AZT; HIV; PWA.
- Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers. Scheid, D.C.; Hamm, R.M.; Stevens, K.W. // PharmacoEconomics;2000, Vol. 18 Issue 4, p355
Objective: The United States Public Health Service (USPHS) published recommendations for human immunodeficiency virus (HIV) postexposure prophylaxis (PEP) of healthcare workers in May 1998. The aim of this study was to analyse the cost effectiveness of the USPHS PEP... - Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies. Hsu, Justine; Zinsou, Cyprien; Parkhurst, Justin; N’Dour, Marguerite; Foyet, Léger; Mueller, Dirk H // Health Policy & Planning;Jan2013, Vol. 28 Issue 1, p20
Background Behavioural interventions have been widely integrated in HIV/AIDS social marketing prevention strategies and are considered valuable in settings with high levels of risk behaviours and low levels of HIV/AIDS awareness. Despite their widespread application, there is a lack of economic...
- Prevention of mother-to-child transmission of HIV infection: Views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi. O'Gorman, Deirdre A.; Nyirenda, Lot J.; Theobald, Sally J. // BMC Public Health;2010, Vol. 10 Issue 1, p354
Background: In 2006 the World Health Organization described the status of prevention of mother to child transmission (PMTCT) service implementation as unacceptable, with an urgent need for a renewed public health approach to improve access. For PMTCT to be effective it needs to be accessible,...
- A Focal Point of HIV Infection. // Family Planning Perspectives;Jan/Feb90, Vol. 22 Issue 1, p5
The article describes the case of a Belgian woman who was diagnosed as having AIDS-related complex. The woman identified an African civil engineer as the only possible source of infection. When the civil engineer was diagnosed with HIV, he gave the names of 19 women with whom he had intercourse...
- Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion. Freedberg, K.A.; Paltiel, A.D. // PharmacoEconomics;1998, Vol. 14 Issue 2, p165
Dramatic progress has recently been made in defining the pathogenesis and treatment of HIV infection. For the first time in the history of the AIDS epidemic, clinicians have at their disposal an understanding of the replication kinetics of HIV, reliable assays to measure viral load, an...
- A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US. Lacey, L.; Mauskopf, J.; Lindrooth, R.; Pham, S.; Saag, M.; Sawyer, W. // PharmacoEconomics;1999 Supplement 1, Vol. 15 Issue 5, p23
Background: Healthcare resource use data were collected for 1 year as part of the CAESAR (Canada, Australia, Europe, South Africa) clinical trial, which evaluated the effect of adding lamivudine to treatment regimens containing zidovudine in patients with HIV infection. This study showed that...
- Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre. Beck, E.J.; Mandalia, S.; Griffith, R.; Beecham, J.; Walters, M.D.S.; Boulton, M.; Miller, D.L.; Walters, M D // PharmacoEconomics;2000, Vol. 17 Issue 1, p53
Objective: To describe the use of hospital and community services for children infected with HIV and estimate the cost per patient-year by stage of HIV infection during the era of antiretroviral monotherapy.Design: Data on the use of hospital services were collected... - Bridging The Resource Gap: Improving Value For Money In HIV/AIDS Treatment. Soni, Anil; Gupta, Rajat // Health Affairs;Nov/Dec2009, Vol. 28 Issue 6, p1617
The world faces both near-term and potentially long-term shortfalls in funding for HIV/AIDS care and treatment. We review the current funding environment, then discuss a range of opportunities to optimize spending on HIV/AIDS. These include (but are not limited to) more use of specific...
